Filtered By:
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 3967 results found since Jan 2013.
Immediate hypersensitivity to parenteral corticosteroids caused by IgE-mediated allergy to carmellose
J Investig Allergol Clin Immunol. 2023 Sep 6:0. doi: 10.18176/jiaci.0938. Online ahead of print.NO ABSTRACTPMID:37675798 | DOI:10.18176/jiaci.0938
Source: Journal of Investigational Allergology and Clinical Immunology - September 7, 2023 Category: Allergy & Immunology Authors: C Gal án A Arrien de Lecea B Bartolom é Zavala M P érez Escalera J S ánchez de Vicente Source Type: research
Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment
As more and better therapies for the treatment of asthma are developed, the approach to classification of asthma control has been in transition. With the availability of inhaled corticosteroids (ICS) as a treatment class came the introduction of control measures utilizing guideline-based criteria, which included validated tools such as the Asthma Control Test (ACT), Baseline Asthma Impairment and Risk Questionnaire (AirQ) and the Asthma Control Questionnaire (ACQ)1,2,3. Following the addition of long-acting bronchodilator (LABA) therapy, Bateman and colleagues described a measure of total control in the GOAL study, definin...
Source: Annals of Allergy, Asthma and Immunology - September 7, 2023 Category: Allergy & Immunology Authors: Michael Blaiss, John Oppenheimer, Mark Corbett, Len Bacharier, Jonathan Bernstein, Tara Carr, Bradley Chipps, Simon Couillard, Erick Forno, Torie Grant, Njira Lugogo, Kathleen May, Eric Schauberger Source Type: research
Managing Anaphylaxis – Epinephrine, Antihistamines, and Corticosteroids: Over 10 years of C-CARE Registry Data
Epinephrine is the first-line treatment for anaphylaxis but is often replaced with antihistamines or corticosteroids. Delayed epinephrine administration is a risk factor for fatal anaphylaxis. Convincing data on the role of antihistamines and corticosteroids in anaphylaxis management is sparse.
Source: Annals of Allergy, Asthma and Immunology - September 6, 2023 Category: Allergy & Immunology Authors: Luca Delli Colli, Adnan Al Ali, Sofianne Gabrielli, Marina Delli Colli, Pasquale Mule, Benjamin Lawson, Ann. E. Clarke, Judy Morris, Jocelyn Gravel, Rod Lim, Edmond S. Chan, Ran D. Goldman, Andrew O'Keefe, Jennifer Gerdts, Derek K. Chu, Julia Upton, Elana Tags: Original Article Source Type: research
The chronic rhinosinusitis practice parameter
Ann Allergy Asthma Immunol. 2023 Sep;131(3):307-310. doi: 10.1016/j.anai.2022.12.022. Epub 2022 Dec 17.ABSTRACTThe Allergy-Immunology Joint Task Force on Practice Parameters has published the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) guidelines for the medical management of chronic rhinosinusitis with nasal polyposis (CRSwNP). The practice parameter provides evidence-based guidelines on the use of intranasal corticosteroids (INCS) and biologics for CRSwNP, and aspirin therapy after desensitization (ATAD) for the management of aspirin-exacerbated respiratory disease (AERD). Evidence on surge...
Source: Annals of Allergy, Asthma and Immunology - September 5, 2023 Category: Allergy & Immunology Authors: So Lim Kim Matthew A Rank Anju Tripathi Peters Source Type: research
From the Pages of AllergyWatch
For this edition of From the Pages of AllergyWatch I've chosen articles from AllergyWatch focusing on atopic dermatitis, the main theme of this month's Annals. The first article, with comments from Dr. Spriet, investigates various biomarkers in stratum corneum tape strips to predict development of atopic dermatitis in infants and young children. The next article, with comments from Dr. Otani, evaluates the need for closer monitoring of the use of corticosteroids in patients with atopic dermatitis.
Source: Annals of Allergy, Asthma and Immunology - August 31, 2023 Category: Allergy & Immunology Authors: Stanley M. Fineman, Sarah Spriet, Iris Otani, Gerald B. Lee Tags: Special Series Source Type: research
An Overview of Nanotechnological Approaches for the Diagnosis and Treatment of Allergic Illness
Curr Pharm Des. 2023 Aug 28. doi: 10.2174/1381612829666230828104015. Online ahead of print.ABSTRACTAllergies are a major health issue. Allergen avoidance, antihistamines, and corticosteroids do not treat the pathology's causes, therefore long-term therapy is essential. Long-term allergen-specific immunotherapy builds immune tolerance to the allergen. Unfortunately, immunotherapies for all allergens are not available, and adverse reactions during therapy, especially in severely allergic persons, remain a worry. In this regard, cell and bio- or nanomaterial-based allergy treatments are promising. This overview covers the mos...
Source: Current Pharmaceutical Design - August 29, 2023 Category: Drugs & Pharmacology Authors: Bhupendra Sharma Rohitas Deshmukh Source Type: research
Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life
CONCLUSION: The most burdensome AEs may not be the AEs that would cause patients to stop therapy. Furthermore, qualitative focus groups suggest a psychosocial burden associated with ICS, which needs further investigation.PMID:37643678 | DOI:10.1016/j.anai.2023.08.595
Source: Annals of Allergy, Asthma and Immunology - August 29, 2023 Category: Allergy & Immunology Authors: Purnadeo N Persaud Annie P Tran Donna Messner J Daryl Thornton Dennis Williams Logan J Harper Vickram Tejwani Source Type: research
Allergic rhinitis guidelines knowledge, attitudes, and practices among primary health care physicians: A national multicentre cross-sectional study
CONCLUSION: Our study demonstrates the importance of education and awareness for PHCPs managing AR. ARIA guidelines should be implemented as a standard of care for AR, as PHCPs are the first ones to encounter patients with AR, to improve outcomes and avoid undertreatment and complications.PMID:37636198 | PMC:PMC10451594 | DOI:10.4103/jfmpc.jfmpc_85_23
Source: Primary Care - August 28, 2023 Category: Primary Care Authors: Hisham Almousa Saad M Alsaad Dawood Ismail Saleh Mahjoub Sultan Bin Obaid Saad Alsaleh Source Type: research
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
CONCLUSION: In a global study, comorbidity or multimorbidity is reported in most adults with severe asthma and is associated with poorer asthma-related outcomes.PMID:37640263 | DOI:10.1016/j.anai.2023.08.021
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ghislaine Scelo Carlos A Torres-Duque Jorge Maspero Trung N Tran Ruth Murray Neil Martin Andrew N Menzies-Gow Mark Hew Matthew J Peters Peter G Gibson George C Christoff Todor A Popov Andr éanne Côté Celine Bergeron Delbert Dorscheid J Mark FitzGerald Source Type: research
Allergic rhinitis guidelines knowledge, attitudes, and practices among primary health care physicians: A national multicentre cross-sectional study
CONCLUSION: Our study demonstrates the importance of education and awareness for PHCPs managing AR. ARIA guidelines should be implemented as a standard of care for AR, as PHCPs are the first ones to encounter patients with AR, to improve outcomes and avoid undertreatment and complications.PMID:37636198 | PMC:PMC10451594 | DOI:10.4103/jfmpc.jfmpc_85_23
Source: Primary Care - August 28, 2023 Category: Primary Care Authors: Hisham Almousa Saad M Alsaad Dawood Ismail Saleh Mahjoub Sultan Bin Obaid Saad Alsaleh Source Type: research
Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life
: A multistakeholder core outcome set created for asthma trials showed that asthma specific quality of life (QoL) was a critically meaningful outcome. However, the definition and how to measure it was undetermined. The adverse effects (AEs) of corticosteroids may be a vital clinical trial outcome. Yet, the AE burden from the patient perspective has not yet been elucidated in an asthma population.
Source: Annals of Allergy, Asthma and Immunology - August 27, 2023 Category: Allergy & Immunology Authors: Purnadeo N. Persaud, Annie P. Tran, Donna Messner, J. Daryl Thornton, Dennis Williams, Logan J. Harper, Vickram Tejwani Tags: Original Article Source Type: research
